# ADRA1B

## Overview
The ADRA1B gene encodes the alpha-1B adrenergic receptor, a member of the G protein-coupled receptor (GPCR) family, which is integral to the sympathetic nervous system's function. This receptor is characterized by its seven transmembrane alpha-helical domains, facilitating its role in signal transduction across the cell membrane. The alpha-1B adrenergic receptor is primarily involved in mediating physiological responses such as vasoconstriction and cardiac contractility by activating intracellular signaling pathways through the Gq/11 protein. Upon activation by catecholamines like norepinephrine, it stimulates phospholipase C, leading to increased intracellular calcium levels essential for smooth muscle contraction. The receptor is expressed in various tissues, including cardiac and smooth muscle, liver, and the central nervous system, where it plays a significant role in regulating vascular tone and blood pressure, thus maintaining cardiovascular homeostasis (Rudner1999Subtype; Docherty2009Subtypes; Ahles2014Polymorphic).

## Structure
The ADRA1B gene encodes the alpha-1B adrenergic receptor, a member of the G protein-coupled receptor (GPCR) family. This receptor is characterized by its seven transmembrane alpha-helical domains, a common feature of GPCRs, which facilitate its role in signal transduction across the cell membrane (Papageorgiou2023ADRA2B; Ahles2014Polymorphic). The primary structure of ADRA1B includes a specific sequence of amino acids that form these transmembrane helices, contributing to its functional conformation (Patrao2007Cloning).

The secondary structure of ADRA1B involves these alpha-helices, which span the cell membrane and are crucial for receptor function. The tertiary structure, although not fully resolved, is inferred through homology modeling with other GPCRs, such as the beta-2 adrenoceptor, due to the lack of crystal structures for ADRA1B (Ahles2014Polymorphic). This modeling suggests a three-dimensional conformation that allows for ligand binding and interaction with G proteins.

Post-translational modifications, such as phosphorylation and glycosylation, are common in GPCRs and likely play a role in the regulation and function of ADRA1B, although specific modifications for ADRA1B are not detailed in the available literature (Ahles2014Polymorphic).

## Function
The ADRA1B gene encodes the alpha-1B adrenergic receptor, a G protein-coupled receptor that plays a crucial role in the sympathetic nervous system. This receptor is primarily involved in mediating vasoconstriction and cardiac contractility by activating intracellular signaling pathways through the Gq/11 protein. Upon activation by catecholamines such as norepinephrine, the alpha-1B adrenergic receptor stimulates phospholipase C, leading to the production of inositol triphosphate and diacylglycerol. These molecules increase intracellular calcium levels, which are essential for smooth muscle contraction and vasoconstriction (Docherty2009Subtypes; Adefurin2016Genetic).

In healthy human cells, the alpha-1B adrenergic receptor is active in the plasma membrane, where it influences cardiovascular functions by regulating vascular tone and blood pressure. It is expressed in various tissues, including cardiac and smooth muscle, liver, and the central nervous system (Ahles2014Polymorphic). The receptor's activity contributes to the regulation of blood pressure and vascular resistance, playing a significant role in maintaining cardiovascular homeostasis (Rudner1999Subtype). Despite its involvement in these processes, the receptor's specific functions in healthy human cells remain less studied compared to its roles in pathological conditions (Ahles2014Polymorphic).

## Clinical Significance


## Interactions
The ADRA1B gene encodes the alpha-1B adrenergic receptor, which is a G protein-coupled receptor involved in various protein interactions. Upon activation by catecholamines, ADRA1B couples with Gq proteins, leading to the activation of phospholipase C (PLC). This activation increases inositol triphosphate (IP3) and intracellular calcium concentrations, which are crucial for signaling pathways in cardiac and smooth muscle tissues (Ahles2014Polymorphic). 

ADRA1B can undergo phosphorylation by protein kinases such as PKA and PKC, as well as by G protein-coupled receptor kinases (GRKs). This phosphorylation recruits beta-arrestins, which prevent further activation of G proteins and promote receptor desensitization and internalization. Beta-arrestins also mediate the activation of mitogen-activated protein kinases (MAPKs), which are involved in various cellular processes (Ahles2014Polymorphic). 

In the context of heart failure, particularly post-ischemic conditions, the expression of ADRA1B is significantly altered. Treatment can modulate its interactions, reducing expression coordination and decoupling ADRA1B from several other genes, such as Akt1, Atf2, Atf4, Atp1a3, Cacnb2, Camk2a, Ppp2r2d, and Ppp2r5d (Iacobas2022Theory). These interactions highlight the dynamic role of ADRA1B in heart function and its potential as a therapeutic target.


## References


[1. (Papageorgiou2023ADRA2B) Louis Papageorgiou, Evangelia Christou, Effrosyni Louka, Eleni Papakonstantinou, Io Diakou, Katerina Pierouli, Konstantina Dragoumani, Flora Bacopoulou, George P. Chrousos, Elias Eliopoulos, and Dimitrios Vlachakis. ADRA2B and HTR1A: An Updated Study of the Biogenic Amine Receptors Reveals Novel Conserved Motifs Which Play Key Role in Mental Disorders, pages 79–99. Springer International Publishing, 2023. URL: http://dx.doi.org/10.1007/978-3-031-31978-5_7, doi:10.1007/978-3-031-31978-5_7. This article has 2 citations.](https://doi.org/10.1007/978-3-031-31978-5_7)

[2. (Iacobas2022Theory) Dumitru Andrei Iacobas and Lei Xi. Theory and applications of the (cardio) genomic fabric approach to post-ischemic and hypoxia-induced heart failure. Journal of Personalized Medicine, 12(8):1246, July 2022. URL: http://dx.doi.org/10.3390/jpm12081246, doi:10.3390/jpm12081246. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jpm12081246)

[3. (Patrao2007Cloning) M. T.C.C. Patrao, D. B.C. Queiroz, G. Grossman, P. Petrusz, M. d. F. M. Lazari, and M. C. W. Avellar. Cloning, expression and immunolocalization of 1-adrenoceptor in different tissues from rhesus monkey and human male reproductive tract. Molecular Human Reproduction, 14(2):85–96, November 2007. URL: http://dx.doi.org/10.1093/molehr/gam084, doi:10.1093/molehr/gam084. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/molehr/gam084)

[4. (Rudner1999Subtype) Xiaowen L. Rudner, Dan E. Berkowitz, John V. Booth, Bonita L. Funk, Kelli L. Cozart, Elizabeth B. D’Amico, Habib El-Moalem, Stella O. Page, Charlene D. Richardson, Bradford Winters, Leo Marucci, and Debra A. Schwinn. Subtype specific regulation of human vascular α 1 -adrenergic receptors by vessel bed and age. Circulation, 100(23):2336–2343, December 1999. URL: http://dx.doi.org/10.1161/01.cir.100.23.2336, doi:10.1161/01.cir.100.23.2336. This article has 223 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/01.cir.100.23.2336)

[5. (Ahles2014Polymorphic) Andrea Ahles and Stefan Engelhardt. Polymorphic variants of adrenoceptors: pharmacology, physiology, and role in disease. Pharmacological Reviews, 66(3):598–637, June 2014. URL: http://dx.doi.org/10.1124/pr.113.008219, doi:10.1124/pr.113.008219. This article has 94 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1124/pr.113.008219)

[6. (Adefurin2016Genetic) A Adefurin, L V Ghimire, U Kohli, M Muszkat, G G Sofowora, C Li, R T Levinson, S Y Paranjape, C M Stein, and D Kurnik. Genetic variation in the alpha1b-adrenergic receptor and vascular response. The Pharmacogenomics Journal, 17(4):366–371, April 2016. URL: http://dx.doi.org/10.1038/tpj.2016.29, doi:10.1038/tpj.2016.29. This article has 7 citations.](https://doi.org/10.1038/tpj.2016.29)

[7. (Docherty2009Subtypes) James R. Docherty. Subtypes of functional α1-adrenoceptor. Cellular and Molecular Life Sciences, 67(3):405–417, October 2009. URL: http://dx.doi.org/10.1007/s00018-009-0174-4, doi:10.1007/s00018-009-0174-4. This article has 152 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-009-0174-4)